The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,810.00
Bid: 1,807.50
Ask: 1,808.50
Change: 10.50 (0.58%)
Spread: 1.00 (0.055%)
Open: 1,797.00
High: 1,810.00
Low: 1,792.00
Prev. Close: 1,799.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET PULSE-Gigatronics, Everyware, Clovis Oncology, Arctic Cat

Mon, 02nd Jun 2014 16:43

(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49s; for the Morning News Call newsletter, http://link.reuters.com/nex49s)U.S. stocks edged lower on Monday, falling from record levels asa weaker-than-expected read on manufacturing gave traders anexcuse to sell. The Dow Jones industrial average was up0.11 percent at 16,735.12 and the S&P 500 was up 0.03percent at 1,924.08.

** GOOGLE INC, $561.33, -1.81 pct

Google services are being disrupted in China ahead of thisweek's 25th anniversary of the 1989 crackdown on pro-democracydemonstrators around Beijing's Tiananmen Square, a censorshipwatchdog said on Monday.

** GIGATRONICS INC, $2.65, +119.01 pct

The company said it had received orders valued at about $6.9million from a major aerospace company for the delivery of YIG(Yttrium Iron Garnet) filters used in wireless communication.Gigatronics did not name the customer but said it "will be asupplier of filter systems for all three of the US designed 4thgeneration fighters." Gigatronics also said it was expecting anorder later this year for about $10 million associated with theproduction units.

** EVERYWARE GLOBAL INC, $1.78, +61.82 pct

The company, which sells dinnerware and kitchen gadgets,said on Saturday that its asset-backed loan lenders agreed notto exercise their rights and remedies till June 30 following adefault on certain covenants.

Everyware said it also intends to partially reopen itsMonaca, Pennsylvania facility.

** BEBE STORES INC, $3.36, -17.55 pct

The women's apparel retailer's Chief Executive SteveBirkhold has sold 140,980 shares of the company at an averageprice of $4.07, a regulatory filing late on Friday revealed. (http://link.reuters.com/beq79v)

** NPS PHARMACEUTICALS INC, $33.92, +8.96 pct

London-listed drugmaker Shire Plc has secured a $5billion credit facility for a takeover offer forNew-Jersey-based NPS Pharmaceuticals, The Times of Londonreported on Sunday. Insiders told The Times that an initialapproach to NPS by Shire has been rebuffed.

** MASTEC INC, $32.18, -10.61 pct

The infrastructure construction company said on Sunday thatit now estimates second-quarter revenue of about $1.1 billion,below its previous forecast of $1.15 billion to $1.2 billion.The company cited lower than previously expected revenue fromwireless projects and the oil and gas segment for the revision.

Stifel Nicolaus cut its price target on the stock to $45from $49 on Monday.

** PROTECTIVE LIFE CORP, $58.5, +11.85 pct

Japanese insurer Dai-ichi Life Co is in advancedtalks to buy U.S. peer Protective Life in a deal that could beworth over $5 billion, extending a drive to buy assets abroad asan antidote to a weak domestic outlook.

** CLOVIS ONCOLOGY,

The company reported positive data from an early stage studytesting its experimental lung cancer drug on Friday, but said 22percent of patients experienced high-blood sugar severe enoughto warrant treatment.

The drug - similar to AstraZeneca Plc's AZD9291 - isdesigned to target non-small cell lung cancer containing agenetic mutation.

** BROADCOM CORP, $34.85, +9.35 pct

The chipmaker said it was looking to sell or wind down itscost-intensive cellular baseband business that is hurting itsoperating income due to high research and development costs.

** ARCTIC CAT INC $33.65, -9.79 pct

The maker of all-terrain vehicles and snowmobiles said ChiefExecutive Claude Jordon has stepped down. The company namedChris Twomey as interim CEO.

** NORDION INC $12.86, +7.62 pct

U.S.-based Sterigenics International has sweetened itstakeover offer for Nordion Inc, the Canadian medicalisotope producer, to $805 million after a previous bid failed toattract enough shareholder support, Nordion said on Monday.

** ARIAD PHARMACEUTICALS INC, $6.94, +7.43 pct

The company said longer-term data from two studies of itsleukemia drug, Iclusig, showed that the drug continues to beeffective in patients who have already received treatment.

Iclusig was allowed a restricted return to the U.S. marketin December, after sales were suspended due to safety concerns.

** JUMEI INTERNATIONAL HOLDING LTD, $29.42, +6.98pct

Brokerage JG Capital initiated coverage on the Chineseonline cosmetics retailer's stock with an "overweight" rating,saying it expects Jumei to benefit from the company's strongbrand awareness, large loyal user base and online shopping'sincreasing penetration in China.

** CONN'S INC, $48.345, +3.66 pct

The electronics and home appliance retailer reported abetter-than-expected profit for the first quarter as furnitureand mattress sales jumped about 65 percent.

** AMERICAN REALTY CAPITAL HEALTHCARE TRUST INC,$10.83, +8.84 pct

** VENTAS INC, $64.49, -3.46 pct

Ventas, one of the largest U.S. healthcare real estateinvestment trusts, said it would buy American Realty CapitalHealthcare Trust in a cash-and-stock deal valued at about $2.6billion.

** PENN VIRGINIA CORP, $14.321, -5.66 pct

The oil and gas producer said it would sell its Mississippiassets to an undisclosed buyer for about $72.7 million. Theassets had net production of about 11.9 million cubic feet ofnatural gas equivalent per day during the first quarter.

** MEADWESTVACO CORP, $42.45, +4.61 pct

Activist investor Starboard Value LP reported a 5.6 percentstake in MeadWestvaco and said the packaging materials maker'sstock was "deeply undervalued".

** CENTURY ALUMINUM CO, $14.095, +3.26 pct

Analysts at BofA Merrill Lynch upgraded the company's stockto "neutral", according to StreetInsider.com.

** EXPRESS INC, $12.52, -0.71 pct

** AEROPOSTALE INC, $3.72, -4.86 pct

Nomura Equity Research cut its price targets on the apparelretailers' stocks. The brokerage cut its price target onExpress's shares to $16 from $20, and on Aeropostale's stock to$5 from $6.

** WALTER ENERGY INC, $4.62, -5.33 pct

** ARCH COAL INC, $3.5, -1.69 pct

** ALPHA NATURAL RESOURCES INC, $3.38, +0.00 pct

** PEABODY ENERGY CORP, $16.2, +0.25 pct

The United States on Monday formally announced a plan toslash carbon emissions from the power sector by 30 percentnationwide below 2005 levels by 2030, a key element of PresidentBarack Obama's plan to tackle global warming.

For a factbox, click

** THERAVANCE BIOPHARMA, $27.94, -2.48 pct

Robert W. Baird & Co analyst Brian Skorney downgraded thebiotechnology company's stock to "neutral" from "outperform",saying, "We think the stock may be particularly volatile in thenear term and see little fundamental upside without betterclarity into acceleration of Breo and Anoro sales."

Breo and Anoro are two FDA-approved treatments developed bythe company in collaboration with GlaxoSmithKline Plc for chronic obstructive pulmonary disease, a serious lungcondition.

Theravance said it would split into two publicly traded U.S.companies in April last year, separating some of its mostadvanced respiratory drugs from its other biopharmaceuticaloperations.

** ALLERGAN INC, $170.25, +1.67 pct

** VALEANT PHARMACEUTICALS INC , $131.39, +0.14 pct

Valeant Pharmaceuticals Inc on Monday prepared totake its $53.8 billion takeover bid for Allergan directly to theBotox maker's shareholders, and ally Pershing Square called fora meeting to turn over the target company's board.

For a BREAKINGVIEWS column,

** RICE ENERGY INC, $31.32, -1.29 pct

** ANTERO RESOURCES CORP, $61.98, +0.78 pct

** CHESAPEAKE ENERGY CORP, $29.21, +1.71 pct

** GULFPORT ENERGY CORP, $61.84, +0.50 pct

** RANGE RESOURCES CORP, $92.54, -0.44 pct

** STONE ENERGY CORP, $43.71, -1.53 pct

Natural gas producer Rice Energy, which went public earlierthis year, said it had successfully tested its first Utica Shalewell in Ohio.

The well, the Bigfoot 9H, had a stabilized production rateof 41.69 million cubic feet per day (mmcf/d) of gas, the companysaid. The market estimate was at about 30 mmcf/d, analysts atTudor, Pickering, Holt & Co said in a note.

The high production rate was a positive for otherexploration and production companies with exposure to the drygas window of the Utica, analysts said.

** AMTRUST FINANCIAL SERVICES INC, $41.43, -2.97pct

An article on Barron's weekly said the property and casualtyinsurer could be under-reserved due to certain accountingdisparities. (http://r.reuters.com/kaq79v)

(Compiled by Shubhankar Chakravorty in Bangalore; Editing bySriraj Kalluvila)

More News
29 Feb 2024 07:22

GSK reaches settlement in another Zantac case

(Sharecast News) - GSK announced a confidential settlement with Boyd/Steenvoord, effectively resolving a case filed in California state court over its discontinued heartburn drug Zantac.

Read more
26 Feb 2024 08:25

GSK gonorrhoea treatment achieves efficacy endpoint in latest trial

(Alliance News) - GSK PLC on Monday announced positive results from the latest trial of its oral gonorrhoea treatment, showing it to be on par with intramuscular therapies.

Read more
26 Feb 2024 07:22

GSK reports positive results from gonorrhoea treatment trial

(Sharecast News) - GSK announced encouraging headline outcomes from its trial of gepotidacin, an oral antibiotic aiming to address uncomplicated urogenital gonorrhoea in adolescents and adults, on Monday.

Read more
21 Feb 2024 09:47

GSK reports encouraging results for ViiV's Cabenuva HIV treatment

(Alliance News) - GSK PLC on Wednesday said that its majority-owned company ViiV Healthcare had received positive interim data from ongoing trials of its injectable HIV treatment.

Read more
21 Feb 2024 07:22

GSK's ViiV sees success in latest HIV treatment trial

(Sharecast News) - GSK's specialist HIV unit ViiV Healthcare, which it owns in partnership with Pfizer and Shionogi, unveiled promising findings from the 'LATITUDE' phase three trial of its long-acting injectable HIV treatment Cabenuva on Wednesday.

Read more
20 Feb 2024 15:10

PRESS: AJ Bell founder to join Applied Nutrition ahead of IPO - Sky

(Alliance News) - Supplements maker Applied Nutrition, plotting a London stock market float, is to add AJ Bell PLC founder Andy Bell as its chair, Sky News reported on Tuesday.

Read more
20 Feb 2024 08:55

IN BRIEF: Diageo welcomes GSK's CFO as non-executive director

Diageo PLC - London-based brewer and distiller sells more than 200 drinks brands, including Guinness stout, Captain Morgan rum and Johnnie Walker whisky - Appoints GSK PLC's chief financial officer and executive director, Julie Brown, as a non-executive director. Says she will succeed Alan Stewart as chair of the audit committee after his retirement following the firm's annual general meeting in September. Chair Javier Ferran says: "Julie brings many years of experience in financial, commercial and strategic roles in international companies operating in highly regulated industries. She is strongly committed to enabling diversity in business and to creating sustainable, long-term value for stakeholders. I look forward to her contribution to Board discussions and to working with her in progressing Diageo's ambition to be one of the most trusted and respected consumer products companies in the world."

Read more
15 Feb 2024 14:44

UK dividends calendar - next 7 days

Friday 16 February 
JPMorgan Asia Growth & Income PLCdividend payment date
JPMorgan Japan Small Cap Growth & Income PLCdividend payment date
Murray International Trust PLCdividend payment date
Premier Miton Group PLCdividend payment date
Schroder Oriental Income Funddividend payment date
Solid State PLCdividend payment date
Monday 19 February 
no events scheduled 
Tuesday 20 February 
Invesco Bond Income Plus Ltd 
Wednesday 21 February 
no events scheduled 
Thursday 22 February 
abrdn Asia Focus PLCex-dividend payment date
Alumasc Group PLCex-dividend payment date
AstraZeneca PLCex-dividend payment date
BlackRock Throgmorton Trust PLCex-dividend payment date
Braemar PLCex-dividend payment date
easyJet PLCex-dividend payment date
Ecofin US Renewables Infrastructure Trust PLCex-dividend payment date
Endeavour Mining PLCex-dividend payment date
FRP Advisory Group PLCex-dividend payment date
Gateley Holdings PLCex-dividend payment date
GSK PLCex-dividend payment date
Hercules Site Services PLCex-dividend payment date
Jersey Electricity PLCex-dividend payment date
Land Securities Group PLCex-dividend payment date
Molten Ventures VCT PLCex-dividend payment date
Northern Bear PLCex-dividend payment date
Redrow PLCex-dividend payment date
Samuel Heath & Sons PLCex-dividend payment date
Titon Holdings PLCex-dividend payment date
Unilever PLCex-dividend payment date
Van Elle Holdings PLCex-dividend payment date
Virgin Money UK PLCex-dividend payment date
Witan Investment Trust PLCex-dividend payment date
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
15 Feb 2024 11:02

Berenberg hikes target price on GSK

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker GSK from £16.50 to £18.20 on Thursday, stating the group was moving closer to offsetting losses associated with the expiry of its patent on HIV drug dolutegravir.

Read more
15 Feb 2024 09:45

LONDON BROKER RATINGS: Jefferies cuts Kingfisher but Citi raises

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
15 Feb 2024 08:49

GSK completes USD1.4 billion purchase of respiratory firm Aiolos Bio

(Alliance News) - GSK PLC on Thursday said it has completed the acquisition of Aiolos Bio Ltd, expanding its respiratory portfolio with a potential "best-in-class" asthma treatment.

Read more
13 Feb 2024 16:53

LONDON MARKET CLOSE: Stocks in red amid sticky US inflation data

(Alliance News) - Stock prices in London closed in the red on Tuesday, after a key US inflation reading came in hotter-than-expected.

Read more
13 Feb 2024 16:21

London close: Stocks fall as US inflation tops expectations

(Sharecast News) - London markets ended the trading day in negative territory on Tuesday, influenced by concerns over higher inflation figures from the United States and a deceleration in wage growth within the UK.

Read more
13 Feb 2024 16:21

London close: Stocks fall as US inflation tops expectations

(Sharecast News) - London markets ended the trading day in negative territory on Tuesday, influenced by concerns over higher inflation figures from the United States and a deceleration in wage growth within the UK.

Read more
13 Feb 2024 12:06

LONDON MARKET MIDDAY: Stocks fall but pound up before US data

(Alliance News) - Stock prices in London were on the decline on Tuesday afternoon, with sentiment tetchy ahead of a US inflation report later.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.